morpholinopropane sulfonic acid has been researched along with Osteoporosis in 1 studies
*Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adler, RA; Colón-Emeric, CS; Igwe, I; Jadhav, J; Lee, R; Lyles, KW; Nelson, RE; Pieper, CF; Robinson, K; Zullig, LL | 1 |
1 trial(s) available for morpholinopropane sulfonic acid and Osteoporosis
| Article | Year |
|---|---|
Protocol for the models of primary osteoporosis screening in men (MOPS) cluster randomized trial.
Topics: Bone Density; Humans; Male; Mass Screening; Morpholines; Osteoporosis; Osteoporotic Fractures; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic | 2022 |